FINWIRES · TerminalLIVE
FINWIRES

CN Rail Q1 Adjusted Earnings, Revenue Dip, But Meet Forecast

作者

-- CN Rail's (CNR.TO) first-quarter adjusted earnings, revenue edged down, the company said on Wednesday, but met forecasts.

Adjusted net income edged down to $1.1 billion, or $1.80 per adjusted diluted share, from $1.16 billion, or $1.85 per share, but met the consensus analyst forecast of $1.80 per share, according to FactSet.

Revenues dipped 1% to $4.38 billion, inline with the consensus forecast of $4.38 billion.

Operating ratio, defined as operating expenses as a percentage of revenues, rose 120 basis points to 64.6%, while the adjusted operating ratio of 64.2%, was an increase of 80 basis points over the prior year period, the company said.

Revenue ton miles (RTMs) also increased 3% during the quarter, which CN Rail said was a record.

For 2026, CN is guiding to "flattish" volume growth in terms of RTMs. It expects that adjusted diluted EPS growth will slightly exceed volume growth.

CN still plans to invest $2.8 billion in its capital program, net of amounts reimbursed by customers.

The company will pay a regular quarterly dividend of $0.915 per share on June 30, to shareholders of record on June 9.

CN Rail shares were last seen down US$0.65, to US$114.25 in U.S. pre-market trading.

相關文章

Australia

紅木信託與卡斯爾萊克成立合資企業收購優質巨額抵押貸款

紅木信託(Redwood Trust,RWT)和卡斯萊克(Castlelake)已達成協議,將成立一家合資企業,收購高達80億美元的優質巨額抵押貸款。卡斯萊克週三宣布了這一消息。 卡斯萊克表示,根據該合資協議,紅木信託旗下的Sequoia平台將負責尋找、匯總並盡職調查符合既定資格標準的貸款。 合資企業的財務細節尚未披露。 紅木信託的股價在周三的交易中下跌了2.2%。Price: $5.63, Change: $-0.12, Percent Change: -2.09%

$RWT
Australia

Terra Innovatum與Conuar合作推進SOLO反應器製造

Terra Innovatum Global (NKLR) 週三宣布,已與核燃料和合金製造商 Conuar 達成合作協議,旨在推進其 SOLO 反應器平台規模化部署所需的製造工藝。 該協議的重點在於開發和標準化鋯合金和不銹鋼結構及功能部件的製造工藝,這些材料對反應器堆芯的性能至關重要。 Terra 也表示,將利用 Conuar 在鋯合金製造方面的專業知識,推進可建造性研究。Price: $5.85, Change: $-0.49, Percent Change: -7.73%

$NKLR
Australia

Ecolab在韓國開設生物製程應用實驗室

藝康集團(Ecolab,股票代號:ECL)週三宣布,其位於韓國東灘的生物製程應用實驗室正式啟用,這是該公司在亞洲的首個此類設施。 藝康集團表示,實驗室支援全方位的製程開發活動,涵蓋從早期測試到大規模生產模擬研究的各個階段。此外,該實驗室還能促進與藝康專家的緊密合作,進而提升純化製程、提高效率,並協助產品達到商業化標準。 藝康集團股價當日下跌超過3%。Price: $258.64, Change: $-8.32, Percent Change: -3.12%

$ECL